Literature DB >> 23990368

A novel adenoviral vector-mediated mouse model of Charcot-Marie-Tooth type 2D (CMT2D).

Ah Jung Seo1, Youn Ho Shin, Seo Jin Lee, Doyeun Kim, Byung Sun Park, Sunghoon Kim, Kyu Ha Choi, Na Young Jeong, Chan Park, Ji-Yeon Jang, Youngbuhm Huh, Junyang Jung.   

Abstract

Charcot-Marie-Tooth disease type 2D is a hereditary axonal and glycyl-tRNA synthetase (GARS)-associated neuropathy that is caused by a mutation in GARS. Here, we report a novel GARS-associated mouse neuropathy model using an adenoviral vector system that contains a neuronal-specific promoter. In this model, we found that wild-type GARS is distributed to peripheral axons, dorsal root ganglion (DRG) cell bodies, central axon terminals, and motor neuron cell bodies. In contrast, GARS containing a G240R mutation was localized in DRG and motor neuron cell bodies, but not axonal regions, in vivo. Thus, our data suggest that the disease-causing G240R mutation may result in a distribution defect of GARS in peripheral nerves in vivo. Furthermore, a distributional defect may be associated with axonal degradation in GARS-associated neuropathies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23990368     DOI: 10.1007/s10735-013-9537-0

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  16 in total

Review 1.  The role of aminoacyl-tRNA synthetases in genetic diseases.

Authors:  Anthony Antonellis; Eric D Green
Journal:  Annu Rev Genomics Hum Genet       Date:  2008       Impact factor: 8.929

2.  Sensitivity and reproducibility in adenoviral infectious titer determination.

Authors:  C Nyberg-Hoffman; P Shabram; W Li; D Giroux; E Aguilar-Cordova
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

3.  Autosomal dominant Charcot-Marie-Tooth axonal neuropathy mapped on chromosome 7p (CMT2D).

Authors:  V Ionasescu; C Searby; V C Sheffield; T Roklina; D Nishimura; R Ionasescu
Journal:  Hum Mol Genet       Date:  1996-09       Impact factor: 6.150

4.  Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations.

Authors:  Kumaraswamy Sivakumar; Theodoros Kyriakides; Imke Puls; Garth A Nicholson; Benoît Funalot; Anthony Antonellis; Nyamkhishig Sambuughin; Kyproula Christodoulou; John L Beggs; Eleni Zamba-Papanicolaou; Victor Ionasescu; Marinos C Dalakas; Eric D Green; Kenneth H Fischbeck; Lev G Goldfarb
Journal:  Brain       Date:  2005-07-13       Impact factor: 13.501

5.  Mapping of a distal form of spinal muscular atrophy with upper limb predominance to chromosome 7p.

Authors:  K Christodoulou; T Kyriakides; A H Hristova; D M Georgiou; L Kalaydjieva; B Yshpekova; T Ivanova; J L Weber; L T Middleton
Journal:  Hum Mol Genet       Date:  1995-09       Impact factor: 6.150

6.  An assessment of mechanisms underlying peripheral axonal degeneration caused by aminoacyl-tRNA synthetase mutations.

Authors:  Morgane Stum; Heather M McLaughlin; Erica L Kleinbrink; Kathy E Miers; Susan L Ackerman; Kevin L Seburn; Anthony Antonellis; Robert W Burgess
Journal:  Mol Cell Neurosci       Date:  2010-11-27       Impact factor: 4.314

7.  Primary structure and functional expression of human Glycyl-tRNA synthetase, an autoantigen in myositis.

Authors:  Q Ge; E P Trieu; I N Targoff
Journal:  J Biol Chem       Date:  1994-11-18       Impact factor: 5.157

8.  Gene expression of mouse choline acetyltransferase. Alternative splicing and identification of a highly active promoter region.

Authors:  H Misawa; K Ishii; T Deguchi
Journal:  J Biol Chem       Date:  1992-10-05       Impact factor: 5.157

9.  Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V.

Authors:  Anthony Antonellis; Rachel E Ellsworth; Nyamkhishig Sambuughin; Imke Puls; Annette Abel; Shih-Queen Lee-Lin; Albena Jordanova; Ivo Kremensky; Kyproula Christodoulou; Lefkos T Middleton; Kumaraswamy Sivakumar; Victor Ionasescu; Benoit Funalot; Jeffery M Vance; Lev G Goldfarb; Kenneth H Fischbeck; Eric D Green
Journal:  Am J Hum Genet       Date:  2003-04-10       Impact factor: 11.025

10.  Acetylcholine synthesis by choline acetyltransferase of a peripheral type as demonstrated in adult rat dorsal root ganglion.

Authors:  Jean-Pierre Bellier; Hiroshi Kimura
Journal:  J Neurochem       Date:  2007-06       Impact factor: 5.372

View more
  6 in total

1.  Neuropathic pain model of peripheral neuropathies mediated by mutations of glycyl-tRNA synthetase.

Authors:  Seo Jin Lee; Ah Jung Seo; Byung Sun Park; Hyun Woo Jo; Youngbuhm Huh
Journal:  J Korean Med Sci       Date:  2014-07-30       Impact factor: 2.153

2.  Effect of Electroacupuncture on the Expression of Glycyl-tRNA Synthetase and Ultrastructure Changes in Atrophied Rat Peroneus Longus Muscle Induced by Sciatic Nerve Injection Injury.

Authors:  Meng Wang; Xiao Ming Zhang; Sheng Bo Yang
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-04       Impact factor: 2.629

Review 3.  Peripheral neuropathy via mutant tRNA synthetases: Inhibition of protein translation provides a possible explanation.

Authors:  Erik Storkebaum
Journal:  Bioessays       Date:  2016-06-28       Impact factor: 4.345

4.  A novel therapeutic target for peripheral nerve injury-related diseases: aminoacyl-tRNA synthetases.

Authors:  Byung Sun Park; Seung Geun Yeo; Junyang Jung; Na Young Jeong
Journal:  Neural Regen Res       Date:  2015-10       Impact factor: 5.135

5.  Anatomical distributional defects in mutant genes associated with dominant intermediate Charcot-Marie-Tooth disease type C in an adenovirus-mediated mouse model.

Authors:  SeoJin Lee; Sandesh Panthi; Hyun Woo Jo; Jaeyoung Cho; Min-Sik Kim; Na Young Jeong; In Ok Song; Junyang Jung; Youngbuhm Huh
Journal:  Neural Regen Res       Date:  2017-03       Impact factor: 5.135

Review 6.  An Integrated Approach to Studying Rare Neuromuscular Diseases Using Animal and Human Cell-Based Models.

Authors:  Timothy J Hines; Cathleen Lutz; Stephen A Murray; Robert W Burgess
Journal:  Front Cell Dev Biol       Date:  2022-01-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.